OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Detection approaches for multidrug resistance genes of leukemia
Ying Du, Baoan Chen
Drug Design Development and Therapy (2017) Vol. Volume 11, pp. 1255-1261
Open Access | Times Cited: 25
Ying Du, Baoan Chen
Drug Design Development and Therapy (2017) Vol. Volume 11, pp. 1255-1261
Open Access | Times Cited: 25
Showing 25 citing articles:
Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
Jing‐Quan Wang, Yuqi Yang, Chao‐Yun Cai, et al.
Drug Resistance Updates (2021) Vol. 54, pp. 100743-100743
Closed Access | Times Cited: 177
Jing‐Quan Wang, Yuqi Yang, Chao‐Yun Cai, et al.
Drug Resistance Updates (2021) Vol. 54, pp. 100743-100743
Closed Access | Times Cited: 177
Detection of the Mitochondrial Membrane Potential by the Cationic Dye JC-1 in L1210 Cells with Massive Overexpression of the Plasma Membrane ABCB1 Drug Transporter
Katarína Elefantová, Boris Lakatoš, Jana Kubíčková, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 1985-1985
Open Access | Times Cited: 153
Katarína Elefantová, Boris Lakatoš, Jana Kubíčková, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 1985-1985
Open Access | Times Cited: 153
CircPAN3 mediates drug resistance in acute myeloid leukemia through the miR-153-5p/miR-183-5p–XIAP axis
Jin Shang, Wei‐Min Chen, Zhihong Wang, et al.
Experimental Hematology (2018) Vol. 70, pp. 42-54.e3
Open Access | Times Cited: 128
Jin Shang, Wei‐Min Chen, Zhihong Wang, et al.
Experimental Hematology (2018) Vol. 70, pp. 42-54.e3
Open Access | Times Cited: 128
MicroRNA in leukemia: Tumor suppressors and oncogenes with prognostic potential
Rajab Mardani, Mohammad Hassan Jafari Najaf Abadi, Mahsa Motieian, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 6, pp. 8465-8486
Closed Access | Times Cited: 69
Rajab Mardani, Mohammad Hassan Jafari Najaf Abadi, Mahsa Motieian, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 6, pp. 8465-8486
Closed Access | Times Cited: 69
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line
Manuela Labbozzetta, Marilia Barreca, Virginia Spanò, et al.
Drug Development Research (2022) Vol. 83, Iss. 6, pp. 1331-1341
Open Access | Times Cited: 24
Manuela Labbozzetta, Marilia Barreca, Virginia Spanò, et al.
Drug Development Research (2022) Vol. 83, Iss. 6, pp. 1331-1341
Open Access | Times Cited: 24
Dissecting multi drug resistance in head and neck cancer cells using multicellular tumor spheroids
Mohammad Azharuddin, Karin Roberg, Ashis Kumar Dhara, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 38
Mohammad Azharuddin, Karin Roberg, Ashis Kumar Dhara, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 38
Triptolide promotes ferroptosis by suppressing Nrf2 to overcome leukemia cell resistance to doxorubicin
Xia Wu, Shangqing Chen, Ke‐Chu Huang, et al.
Molecular Medicine Reports (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 19
Xia Wu, Shangqing Chen, Ke‐Chu Huang, et al.
Molecular Medicine Reports (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 19
Arctigenin enhances the sensitivity of cisplatin resistant colorectal cancer cell by activating autophagy
Yuzhen Wang, Lina Li, Li Xu, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 520, Iss. 1, pp. 20-26
Closed Access | Times Cited: 31
Yuzhen Wang, Lina Li, Li Xu, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 520, Iss. 1, pp. 20-26
Closed Access | Times Cited: 31
The Alternating Access Mechanism in Mammalian Multidrug Resistance Transporters and Their Bacterial Homologs
Shadi A. Badiee, Ugochi H. Isu, Ehsaneh Khodadadi, et al.
Membranes (2023) Vol. 13, Iss. 6, pp. 568-568
Open Access | Times Cited: 10
Shadi A. Badiee, Ugochi H. Isu, Ehsaneh Khodadadi, et al.
Membranes (2023) Vol. 13, Iss. 6, pp. 568-568
Open Access | Times Cited: 10
Stable isotope tracing reveals glucose metabolism characteristics of drug-resistant B-cell acute lymphoblastic leukemia
Rong Hu, Zhengwei Duan, Mengyao Wang, et al.
Analytica Chimica Acta (2025), pp. 343884-343884
Closed Access
Rong Hu, Zhengwei Duan, Mengyao Wang, et al.
Analytica Chimica Acta (2025), pp. 343884-343884
Closed Access
Induction of Cuproptosis by Dichloromethane Extract From Patrinia scabiosaefolia Fisch on K562 Cells
Yuan Lü, Leyuan Mi, Peipei Zhang, et al.
Environmental Toxicology (2025)
Closed Access
Yuan Lü, Leyuan Mi, Peipei Zhang, et al.
Environmental Toxicology (2025)
Closed Access
Flavonoids as Chemosensitizers in Leukemias
Nigar Huseynova, Melisa Çetinkaya, Züleyha Baran, et al.
Advances in experimental medicine and biology (2024)
Closed Access | Times Cited: 1
Nigar Huseynova, Melisa Çetinkaya, Züleyha Baran, et al.
Advances in experimental medicine and biology (2024)
Closed Access | Times Cited: 1
Matrine reverses the drug resistance of K562/ADM cells to ADM and VCR via promoting autophagy
Li Zhao, Ning Wang, Ting Yue, et al.
Translational Cancer Research (2020) Vol. 9, Iss. 2, pp. 786-794
Open Access | Times Cited: 11
Li Zhao, Ning Wang, Ting Yue, et al.
Translational Cancer Research (2020) Vol. 9, Iss. 2, pp. 786-794
Open Access | Times Cited: 11
Clinical and Prognostic Significance of Cell Sensitivity to Chemotherapy Detected In Vitro on Treatment Response and Survival of Leukemia Patients
М. А. Колесникова, Aleksandra V. Sen’kova, Sofia Tairova, et al.
Journal of Personalized Medicine (2019) Vol. 9, Iss. 2, pp. 24-24
Open Access | Times Cited: 10
М. А. Колесникова, Aleksandra V. Sen’kova, Sofia Tairova, et al.
Journal of Personalized Medicine (2019) Vol. 9, Iss. 2, pp. 24-24
Open Access | Times Cited: 10
Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen
He‐Wen Wang, Ke-Ling Ma, Hua Liu, et al.
Aging (2020) Vol. 12, Iss. 7, pp. 6018-6029
Open Access | Times Cited: 8
He‐Wen Wang, Ke-Ling Ma, Hua Liu, et al.
Aging (2020) Vol. 12, Iss. 7, pp. 6018-6029
Open Access | Times Cited: 8
Artesunate enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant chronic myeloid leukemia K562/ADR cells
Li Chen, Chao Wang, Ning Hu, et al.
RSC Advances (2019) Vol. 9, Iss. 2, pp. 1004-1014
Open Access | Times Cited: 7
Li Chen, Chao Wang, Ning Hu, et al.
RSC Advances (2019) Vol. 9, Iss. 2, pp. 1004-1014
Open Access | Times Cited: 7
LncRNA-PAX8-AS1 Silencing Decreases Cell Viability, Enhances Apoptosis, and Suppresses Doxorubicin Resistance in Myeloid Leukemia via the miR-378g/ERBB2 Axis
Xiaolu Song, Yirui Chen, Peng Ye, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 4
Xiaolu Song, Yirui Chen, Peng Ye, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 4
PARP Inhibitors as Therapeutic Options for Tyrosine Kinase-dependent Leukemia: A Review
Caio Bezerra Machado, Emerson Lucena da Silva, Manoel Odorico de Moraes, et al.
Anticancer Research (2020) Vol. 40, Iss. 6, pp. 3055-3063
Open Access | Times Cited: 5
Caio Bezerra Machado, Emerson Lucena da Silva, Manoel Odorico de Moraes, et al.
Anticancer Research (2020) Vol. 40, Iss. 6, pp. 3055-3063
Open Access | Times Cited: 5
Induction of Drug-Resistance and Production of a Culture Medium Able to Induce Drug-Resistance in Vinblastine Untreated Murine Myeloma Cells
Valentina Laghezza Masci, Davide Stefanoni, Angelo D’Alessandro, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2051-2051
Open Access | Times Cited: 1
Valentina Laghezza Masci, Davide Stefanoni, Angelo D’Alessandro, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2051-2051
Open Access | Times Cited: 1
Drug responsiveness of leukemic cells detected in vitro at diagnosis correlates with therapy response and survival in patients with acute myeloid leukemia
М. А. Колесникова, Aleksandra V. Sen’kova, Т. И. Поспелова, et al.
Cancer Reports (2021) Vol. 4, Iss. 4
Open Access | Times Cited: 2
М. А. Колесникова, Aleksandra V. Sen’kova, Т. И. Поспелова, et al.
Cancer Reports (2021) Vol. 4, Iss. 4
Open Access | Times Cited: 2
Mechanisms of Drug Resistance in Acute Myeloid Leukemia
Н. М. Боброва, T. V. Romanovskaya
Biology Bulletin Reviews (2021) Vol. 11, Iss. S1, pp. 32-46
Closed Access | Times Cited: 2
Н. М. Боброва, T. V. Romanovskaya
Biology Bulletin Reviews (2021) Vol. 11, Iss. S1, pp. 32-46
Closed Access | Times Cited: 2
Multicellular tumor spheroids- an effectivein vitromodel for understanding drug resistance in head and neck cancer
Mohammad Azharuddin, Karin Roberg, Ashis Kumar Dhara, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access
Mohammad Azharuddin, Karin Roberg, Ashis Kumar Dhara, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access
Efeito do secretoma das células-tronco mesenquimais na expressão de genes de resistência a múltiplas drogas das linhagens hematológicas K562 e K562 Lucena
Fábio Alessandro de Freitas
(2022)
Open Access
Fábio Alessandro de Freitas
(2022)
Open Access
CD44 enhances adriamycin resistance in chronic myelogenous leukaemia cells K562
Juan Li, Yanfang Zhang, Yubo Cui, et al.
International Journal of Laboratory Hematology (2021) Vol. 43, Iss. 5, pp. 983-989
Closed Access
Juan Li, Yanfang Zhang, Yubo Cui, et al.
International Journal of Laboratory Hematology (2021) Vol. 43, Iss. 5, pp. 983-989
Closed Access
